John Clare

Engage with government departments on the creation of a regulated export regime that allows for authorized commercial exportation of industrial hemp-derived CBD and CBD-containing consumer, personal care, and food products. Engage with government departments for more flexible conditions around excise duty stamps and when the stamps are to be affixed engage officials for the purpose of the Cannabis Strategy Table Communicate with government departments regarding the legislated review of the Cannabis Act

Advocacy with the federal government on future legislation, regulation, or policy surrounding the commitment to legalize, regulate, and restrict access to marijuana for recreational purposes.

Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Cannabis Act SC 2018 S16 Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Canada's policy regarding the rules governing the legalization of marijuana

Governmental policy towards medical cannabis research, product quality standards, medical cost coverage, and displacement of harder and more addictive drugs Regulations affiliated with Bill C- 45 regarding the legalization of cannabis. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Formerly known as Bill C-45: An Act Respecting Cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts. Cannabis Act SC 2018 S16 Cannabis Act; phased implementation of the Act and its impact on medical patients; development of regulations for the industry and the resulting tax implications of these regulations. Canada's policy regarding the rules governing the legalization of marijuana

Discuss with the government critical barriers to providing innovative medical cannabis treatments for patients under the current implementation of the Cannabis Act.

Seek amendments to the regulations and policies that govern the importation and exportation of medical cannabis. Elimination of the Health Canada annual 2.3% regulatory fee. Development of a framework to ensure consistent approach to the measurement and labeling of potency of cannabis products Amend the Excise Duty Framework for on Cannabis products to remove the $1.00 per gram duty with a 10% ad valorem rate. Amend the cannabis regulatory framework to permit cannabis licensed producers to more effectively communicate on the attributes of cannabis products with consumers. Amend the cannabis excise duty framework to eliminate the requirement that cannabis producers affix provincial / territory designated excise duty stamps to each individual package of cannabis, to be replaced by either a national excise duty stamp or a digital excise duty stamp.

Engage with the federal government on Metrc’s SaaS cannabis regulatory systems and work with US governments to track and trace cannabis from growth, harvest, and processing to testing, transport and sale.